YMAB - Y-mAbs Therapeutics, Inc.

QQQ $ 594.33 $ 0.00 (0 %)

DIA $ 458.20 $ 0.00 (0 %)

SPY $ 656.72 $ 0.00 (0 %)

TLT $ 91.12 $ 0.00 (0 %)

GLD $ 380.10 $ 0.00 (0 %)

Previous Close

$ 8.61

Open

$ 8.59

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

-- - --

52 Week Range

$ 3.55 - $ 16.11

Volume

760,675

Average Volume

Market Cap

391.22M

Beta (5Y Monthly)

$ 1.75

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2025	06-30-2025	10-Q
2	05-13-2025	03-31-2025	10-Q
3	03-04-2025	01-01-1970	10-K
4	11-08-2024	09-30-2024	10-Q
5	08-12-2024	06-30-2024	10-Q
6	05-07-2024	03-31-2024	10-Q
7	02-29-2024	12-31-2023	10-K
8	11-13-2023	09-30-2023	10-Q
9	08-10-2023	06-30-2023	10-Q
10	05-08-2023	03-31-2023	10-Q
11	03-30-2023	12-31-2022	10-K
12	11-07-2022	09-30-2022	10-Q
13	08-08-2022	06-30-2022	10-Q
14	05-09-2022	03-31-2022	10-Q
15	03-01-2022	12-31-2021	10-K
16	11-04-2021	09-30-2021	10-Q
17	08-09-2021	06-30-2021	10-Q
18	05-06-2021	03-31-2021	10-Q
19	03-01-2021	12-31-2020	10-K
20	11-05-2020	09-30-2020	10-Q
21	08-06-2020	06-30-2020	10-Q
22	05-07-2020	03-31-2020	10-Q
23	03-12-2020	12-31-2019	10-K
24	11-13-2019	09-30-2019	10-Q
25	08-14-2019	06-30-2019	10-Q
26	05-10-2019	03-31-2019	10-Q
27	03-22-2019	12-31-2018	10-K
28	11-13-2018	09-30-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

deal-dispatch-performance-food-group-and-claires-lead-a-week-of-big-auctions-retail-woes

Deal Dispatch: Performance Food Group And ...
08/08/2025 20:02:31

Performance Food rejects offer; Lufthansa drops Air Europa bid; NFL inks deal with ESPN; Claire's files bankruptcy amid ret...

Y-mAbs Therapeutics Q2 EPS $(0.07) Beats $...
08/08/2025 10:36:12

Earnings Scheduled For August 8, 2025
08/08/2025 08:32:13

A Look Ahead: Y-mAbs Therapeutics's Earnin...
08/07/2025 16:03:39

HC Wainwright & Co. Downgrades Y-mAbs Ther...
08/06/2025 12:10:15

HC Wainwright & Co. analyst Robert Burns downgrades Y-mAbs Therapeutics (NASDAQ:YMAB) from Buy to Neutral and lowers the...

Canaccord Genuity Downgrades Y-mAbs Therap...
08/06/2025 11:06:51

Canaccord Genuity analyst Bill Maughan downgrades Y-mAbs Therapeutics (NASDAQ:YMAB) from Buy to Hold and lowers the price ta...

Jones Trading Downgrades Y-mAbs Therapeuti...
08/05/2025 21:02:55

Jones Trading analyst Justin Walsh downgrades Y-mAbs Therapeutics (NASDAQ:YMAB) from Buy to Hold.

nasdaq-down-50-points-ism-services-pmi-declines-in-july

Nasdaq Down 50 Points; ISM Services PMI De...
08/05/2025 17:48:13

12 Health Care Stocks Moving In Tuesday's ...
08/05/2025 17:06:56

dow-surges-over-100-points-pfizer-earnings-top-views

Dow Surges Over 100 Points; Pfizer Earning...
08/05/2025 13:59:13

Trading Halt: Halt status updated at 8:45:...
08/05/2025 12:45:09

Serb Pharmaceuticals Announces They Have E...
08/05/2025 12:33:35

SERB Pharmaceuticals ("SERB"), a global specialty pharmaceutical company focused on medicines for rare diseases and med...

Trading Halt: Halted at 8:25:00 a.m. ET - ...
08/05/2025 12:25:04

12 Health Care Stocks Moving In Friday's A...
08/01/2025 21:06:34

12 Health Care Stocks Moving In Thursday's...
07/31/2025 21:07:05

12 Health Care Stocks Moving In Wednesday'...
07/23/2025 21:05:58

12 Health Care Stocks Moving In Friday's P...
06/27/2025 12:07:16

Oppenheimer Maintains Outperform on Y-mAbs...
05/29/2025 16:37:21

Oppenheimer analyst Jeff Jones maintains Y-mAbs Therapeutics (NASDAQ:YMAB) with a Outperform and lowers the price target fro...

Reported Monday, Y-mAbs Highlights Ongoing...
05/27/2025 06:24:14

The trial in progress poster titled "A phase 1 trial of pretargeted radioimmunotherapy with GD2-SADA: 177Lu-DOTA in patient...

What 7 Analyst Ratings Have To Say About Y...
05/19/2025 12:00:25